Psychosomatic Medicine Tips for Better Browsing
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kripke, D. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kripke, D. F.
Related Collections
Right arrow Sleep and Biological Rhythms
Psychosomatic Medicine 65:74 (2003)
© 2003 American Psychosomatic Society


EDITORIAL COMMENT

Sleep and Mortality

Daniel F. Kripke, MD

University of California, San Diego, 9500 Gilman Drive, La Jolla, CA 92093-0667, Email: DKripke@UCSD.edu

Dew et al. provide the first objective EEG evidence that disturbances of sleep predict a shortened life span (1). Those elderly volunteers with sleep latency >30 minutes (25.5% of the sample) had a relative mortality hazard of 2.14 compared with the others with p < .005, a significance that met Bonferroni criteria. This means that those who needed >30 minutes to fall asleep were more than twice as likely to die over a mean follow-up of 12.8 years, other things being equal. The study was well controlled to exclude any confounding of sleep disturbance with psychiatric disorders. There was also control for age, gender, and medical burden, which is a catch-all metric for controlling for numerous medical comorbidities.

Poor sleep efficiency (a higher percentage of time in bed spent awake) was also a predictor of mortality, but this measure included the effect of sleep latency. Without considering sleep latency, sleep maintenance had only a marginal association with mortality. Surprisingly, the study did not suggest that too little sleep caused increased mortality. Total sleep time was not a significant hazard predictor, even though 40% of the sample slept less than 6.0 hours in bed. A marginally significant effect of either high or low rapid eye movement (REM) sleep percentage was also reported. Because this seems an artificial way of summarizing REM sleep, and other measures of REM sleep were not significant, this effect would need replication. Indeed, as the authors strongly urge, the entire study needs replication. Perhaps there are other research groups who can find sufficient sleep data already collected to replicate the study.

What could be causing this excess mortality? If short sleep and depression are not the cause of the excess mortality, other plausible possibilities mentioned by the authors would be sleep apnea, circadian rhythm disorganization, and impending dementia. Napping might be a cause of circadian rhythm disorganization, but reciprocally, napping might reflect deterioration of the suprachiasmatic nucleus (an important body clock regulating sleep-wake), which seems to undergo early damage in Alzheimer’s disease (2). Although the subjects were asked not to nap, many elders do nap during the day, often involuntarily and sometimes without being aware of it. Napping could cause increased sleep latency, poor sleep efficiency, and even altered REM sleep percentage, all of which could be stigmata of the underlying pathophysiologic processes.

What should be done? Recognized short-term treatments for a long sleep latency include hypnotic drugs and behavioral therapy (3, 4). Continuous positive airway pressure is a recognized treatment for sleep apnea. None of these treatments has been studied on a long-term scale sufficient to evaluate its effect on mortality. As we expand epidemiologic evidence of possible risks of sleep disorders, long-term clinical trials will be necessary both to explore causality and to demonstrate solutions.

REFERENCES

  1. Dew MA, Hoch CC, Buysse DJ, Monk T, Begley AE, Houck PR, Hall M, Kupfer DJ, Reynolds CF III. Healthy older adults’ sleep predicts all-cause mortality at 4 to 19 years of follow-up. Psychosom Med 2003; 65: 63–73.[Abstract/Free Full Text]
  2. Swaab DF, Fisser B, Kamphorst W, Troost D. The human suprachiasmatic nucleus: neuropeptide changes in senium and Alzheimer’s disease. Basic Appl Histochem 1988; 32: 43–54.[Medline]
  3. Smith MT, Perlis ML, Park A, Smith MS, Pennington J, Giles DE, Buysse DJ. Comparative meta-analysis of pharmacotherapy and behavior therapy for persistent insomnia. Am J Psychiatry 2002; 159: 5–11.[Abstract/Free Full Text]
  4. Morin CM, Colecchi C, Stone J, Sood R, Brink D. Behavioral and pharmacological therapies for late-life insomnia: a randomized controlled trial. JAMA 1999; 281: 991–9.[Abstract/Free Full Text]




This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kripke, D. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kripke, D. F.
Related Collections
Right arrow Sleep and Biological Rhythms


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS